PUBLICATIONS & PRESENTATIONS

Scientific Publications

Bridges RJ, Lutgen V, Lobner D, Baker DA. Thinking outside the cleft to understand synaptic activity: contribution of the cysteine-glutamate antiporter (system xC-) to normal and pathological glutamatergic signaling. Pharmacol Rev. 2012. 64(3): 780-802.
READ IT ONLINE

Baker DA, Xi Z-X, Shen H, Swanson CJ, Kalivas PW. The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate.  J Neurosci. 2002. 22 (20): 9134-9141.
READ IT ONLINE

Bridges RJ, Natale NR, Patel SA. System xc- cysteine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol. 2012. 165(1): 20-34.
READ IT ONLINE

 

Scientific Presentations

C. E. BEYER, M. P. NEARY, D. G. LAWTON, M. PREIGH, N. J. RADDATZ, D. C. LOBNER, J. R. MANTSCH, D. A. BAKER. SXC-2023: Preclinical characterization of a novel activator of the cystine glutamate antiporter (System xc-) and potential therapeutic for CNS disorders. Society for Neuroscience, 2017. Presentation No.: 610.13 / RR31.

Beyer CE, Neary MP, Raddatz N, Lobner DC, Mantsch JR, Lawton DG, Baker DA. Targeting xCT (the cysteine-glutamate antiporter) for the treatment of CNS disorders. Program No. 713.20/BB7. 2014 Neuroscience Meeting Planner. Washington, D.C.: Society for Neuroscience, 2014. Online.


Events

47th Annual Society for Neuroscience (SFN) meeting
Date: Tuesday, November 14, 2017
Poster Presentation Time: 1:00 p.m. – 2:00 p.m. Eastern Time
Poster Number: 610.13 / RR31
Title: SXC-2023: Preclinical Characterization of a Novel Activator of the Cystine Glutamate Antiporter (System xc–) and Potential Therapeutic for CNS Disorders